Skip to main content
. 2025 Aug 19;25(1):296. doi: 10.1007/s10238-025-01770-4

Table 3.

Comparison of the pT stages of RCC patients in five periods

pT1 + pT2 pT3 + pT4 χ2 P
N Ratio/% N Ratio/%
2013–2014 (N = 1392) 1232 87.5 160 11.5 32.628 0.000
2015–2016 (N = 1718) 1439 83.8 279 16.2
2017–2018 (N = 1903) 1612 84.7 291 15.3
2019–2020 (N = 1873) 1524 81.4 349 18.6
2021–2022 (N = 2110) 1797 85.1 313 14.9

* RCC, renal cell carcinoma; pT, pathological T